The electron of antibodies fixed in vivo the skin level in pemphigus, bullous pemphigoid and lupus erythematosus
Thivolet, J.; Beyvin, A.J.; Le Mot, J.
Lyon Medical 227(3): 241-245
1972
ISSN/ISBN: 0024-7790 PMID: 5037158 Document Number: 50691
Document emailed within 1 workday
Related Documents
Korman, N.J.; Stanley, J.R.; Woodley, D.T. 1991: Coexistence of pemphigus foliaceus and bullous pemphigoid. Demonstration of autoantibodies that bind to both the pemphigus foliaceus antigen complex and the bullous pemphigoid antigen Archives of Dermatology 127(3): 387-390Lohrisch, I.; Noack, H.; Haustein, U.F.; Sparmann, G.; Koch, J. 1985: Trials on bulla induction by antibodies from bullous pemphigoid patients in vivo and in vitro Dermatologische Monatschrift 171(2): 106-112
Patel, H.P.; Anhalt, G.J.; Diaz, L.A. 1983: Bullous pemphigoid and pemphigus vulgaris Annals of Allergy 50(3): 144-150
White, I.R.; Morgan, E.; MacDonald, D.M. 1979: An immunoperoxidase technique in light and electron microscopy in the evaluation of bullous disorders and lupus erythematosus British Journal of Dermatology 101(Suppl 17): 25-26
Hertl, M.; Büdinger, L.; Christophoridis, S.; Yancey, K.B.; Borradori, L. 1999: IgG and IgA antibodies in linear IgA/IgG bullous dermatosis target the ectodomain of bullous pemphigoid antigen 2 British Journal of Dermatology 140(4): 750-752
Flotte, T.J.; Baird, L.G. 1986: Immunoglobulin light and heavy chain isotypes in skin diseases: restricted distribution in bullous pemphigoid and linear IgA bullous dermatosis Journal of Immunology 136(2): 491-496
Roujeau, J.C.; Ingen-Housz-Oro, S.; Leroux, C.; Joly, P. 2009: Treatment of bullous pemphigoid and pemphigus. The French experience, 2009 update Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 144(4): 333-338
Bardach, H. 1982: ANF-negative subacute cutaneous lupus erythematosus with anti-Ro antibodies. a new subset of lupus with characteristic skin manifestations Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 33(10): 537-541
Halevy, S.; Ben-Bassat, M.; Joshua, H.; Hazaz, B.; Feuerman, E.J. 1979: Immunofluorescent and electron-microscope findings in the uninvolved skin of patients with systemic lupus erythematosus Acta Dermato-Venereologica 59(5): 427-433
Bialynicki-Birula, R.K.; Kobuszewska, A.; Kolodziej, T. 2011: Determination of C1q in vivo increases the sensitivity of direct immunofluorescence test in diagnosing bullous pemphigoid Acta Dermatovenerologica Croatica: Adc 19(4): 271-273
Teikemeier, G.; Kind, P.; Goerz, G. 1988: Bullous systemic lupus erythematosus Zeitschrift für Hautkrankheiten 63(4): 320-325
Asbrink, E.; Hovmark, A. 1984: Serum IgE levels in patients with bullous pemphigoid and its correlation to the activity of the disease and anti-basement membrane zone antibodies Acta Dermato-Venereologica 64(3): 243-246
Nasongkhla, P.; Pratchyapruit, W.; Tagami, H. 2012: Bullous systemic lupus erythematosus induced by UVB: report a case Journal of the Medical Association of Thailand 95(7): 969-973
Heard, M.G. 1976: Fluorescent antibody patterns in bullous dermatoses and lupus erythematosus Journal of the Florida Medical Association 63(1): 42-44
Johns, A.S.; Chamley, L.; Ockelford, P.A.; Pattison, N.S.; McKay, E.J.; Corkill, M.; Hart, H. 1994: Comparison of tests for the lupus anticoagulant and antiphospholipid antibodies in systemic lupus erythematosus Clinical and Experimental Rheumatology 12(5): 523-526
Abdel Gawad, E.R.; Mansour, A.I.; Abdel Aziz, Y.A.; Soliman, A.F.; Fawzy, R.M. 2014: Role of anti-nucleosome antibodies in the diagnosis of systemic lupus erythematosus and as a marker for lupus nephropathy Egyptian Journal of Immunology 21(1): 57-65
Cardinali, C.; Caproni, M.; Fabbri, P. 1999: The utility of the lupus band test on sun-protected non-lesional skin for the diagnosis of systemic lupus erythematosus Clinical and Experimental Rheumatology 17(4): 427-432
D'Cruz, D.P.; Mellor-Pita, S.; Joven, B.; Sanna, G.; Allanson, J.; Taylor, J.; Khamashta, M.A.; Hughes, G.R.V. 2004: Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies Journal of Rheumatology 31(2): 280-285
López-Longo, F.J.; Monteagudo, I.; González, C.M.; Moreno, A.C.; Rodríguez Mahou, M.; Grau, R.; Carreño, L. 1998: Anti-BB'-Sm antibodies, anticardiolipin antibodies, and thrombosis in systemic lupus erythematosus Journal of Rheumatology 25(9): 1743-1749
Horbach, D.A.; van Oort, E.; Donders, R.C.; Derksen, R.H.; de Groot, P.G. 1996: Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies Thrombosis and Haemostasis 76(6): 916-924